Here’s Why Centene Stock Is A Better Bet Compared To This Pharmaceuticals Bellwether
- Wednesday, May 18, 2022, 7:14
- Market
- Add a comment
We think that Centene stock (NYSE: CNC) currently is a better pick compared to the pharmaceuticals bellwether Johnson & Johnson stock (NYSE: JNJ), given Centene’s better prospects and comparatively lower valuation.
About the Author
admin123 has written 23527 stories on this site.
